Anthony Spadaro, MD

Emergency Medicine
Accepting new patients
Sees patients age 18 and up
Penn Emergency Medicine - Clifton Center for Medical Breakthroughs
Call 215-662-4000
Penn Medicine Provider

About me

  • Assistant Professor of Emergency Medicine at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: Rutgers New Jersey Medical School

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Spadaro is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Spadaro A, Hairston J, Lakamana S, Wightman R, Love JL, Perrone J, Sarker A. Characterization of Reddit Posts About Xylazine-Associated Wounds: Qualitative Study , JMIR Dermatol, 8: 2025,e70329

Spadaro A, Calello DP, Counts CJ, Cerbini TA, Nelson LS, Greller HA Rapid transition from a continuous naloxone infusion to sublingual buprenorphine after an opioid overdose: a case series , Subst Use Addctn J: 2025

Thakrar A, Zwiebel S, Christine P, Spadaro A, Davis M, Bhatia R, Rohacs N, Xu L, Perrone J, Lowenstein M Manifestations of a Potential Xylazine Withdrawal Syndrome Among Hospitalized Patients: A Retrospective Cohort Study with Nested Case Control , Drug Alcohol Depend: 2025

Spadaro A, Nath J, Mok T, Chen C, Nelson LS, Santos C Parenteral Buprenorphine for Opioid Withdrawal , J Stud Alcohol Drugs, 86(3): 2025

Spadaro A, Perrone J, Nelson L, Greller HA Reining It In: Xylazine Overdose , Critical Decisions in Emergency Medicine, 39(5): 2025

Counts CJ, Spadaro A, Cerbini T, Krotulski AJ, Greller HA, Nelson LS, Ruck B, Calello DP An Outbreak of Synthetic Cannabinoid-Adulterated Tianeptine Products in New Jersey – A Case Series , J Med Toxicol, 21(2): 2025,253-259

Das S, Ge Y, Guo Y, Rajwal S, Hairston J, Powell J, Walker D, Peddireddy S, Lakamana S, Bozkurt S, Reyna M, Sameni R, Xiao Y, Kim S, Chandler R, Hernandez N, Mowery D, Wightman R, Love J, Spadaro A, Perrone J, Sarker A Two-Layer Retrieval-Augmented Generation Framework for Low-Resource Medical Question Answering Using Reddit Data: Proof-of-Concept Study , J Med Internet Res, 6(27): 2025

Spadaro A, Imperato N, Scalgione J, Santos C. Intravenous Buprenorphine Reversed Opioid-Induced Respiratory Depression Without Precipitating Withdrawal in Emergency Department Patients. , J Stud Alcohol Drugs: 2025

Hairston J, Ranjan R, Lakamana S, Spadaro A, Bozkurt S, Perrone J, Sarker A. Automating inductive thematic analyses of health content using large language models: a proof-of-concept study using social media data. , JAMIA Open: 2025

Javed, J, Spadaro A, Cinnevert E, Simmons B, Gordon E GLP-1 Agonists in patients with cardiovascular disease and comorbid substance use disorder: a retrospective observational cohort study , American Heart Association Annual Meeting: 2024

View all publications